Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|
SK-BR-3 | 0 | uM | 4 | 1250.00 | 814.29 | 1310.00 | 1680.75 | 0.7794 | 0.5758 | |
SK-BR-3 | Methotrexate | 0.31623 | uM | 4 | 1250.00 | 814.29 | 1348.00 | 1680.75 | 0.8020 | 0.6195 |
SK-BR-3 | Palbociclib | 19.9526 | uM | 4 | 1250.00 | 814.29 | 828.00 | 1680.75 | 0.4926 | 0.0161 |
SK-BR-3 | Methotrexate | 0.0016596 | uM | 4 | 1250.00 | 814.29 | 1459.00 | 1680.75 | 0.8681 | 0.7469 |
SK-BR-3 | 0 | uM | 4 | 1250.00 | 814.29 | 1970.00 | 1680.75 | 1.1721 | 1.3281 | |
SK-BR-3 | Taxol | 0.31623 | uM | 4 | 1250.00 | 814.29 | 618.00 | 1680.75 | 0.3677 | -0.2319 |
SK-BR-3 | Palbociclib | 0.01 | uM | 4 | 1250.00 | 814.29 | 1554.00 | 1680.75 | 0.9246 | 0.8555 |
SK-BR-3 | Taxol | 1 | uM | 4 | 1250.00 | 814.29 | 710.00 | 1680.75 | 0.4224 | -0.1229 |
SK-BR-3 | Taxol | 0.0031623 | uM | 4 | 1250.00 | 814.29 | 944.00 | 1680.75 | 0.5617 | 0.1519 |
SK-BR-3 | 0 | uM | 4 | 1250.00 | 814.29 | 1847.00 | 1680.75 | 1.0989 | 1.1888 | |
SK-BR-3 | 0 | uM | 4 | 1250.00 | 814.29 | 1569.00 | 1680.75 | 0.9335 | 0.8726 | |
SK-BR-3 | Palbociclib | 0.031623 | uM | 4 | 1250.00 | 814.29 | 1346.00 | 1680.75 | 0.8008 | 0.6172 |
SK-BR-3 | Methotrexate | 0.0033113 | uM | 4 | 1250.00 | 814.29 | 1802.00 | 1680.75 | 1.0721 | 1.1378 |
SK-BR-3 | Methotrexate | 1 | uM | 4 | 1250.00 | 814.29 | 1331.00 | 1680.75 | 0.7919 | 0.6000 |
SK-BR-3 | Omipalisib | 0.1 | uM | 4 | 1250.00 | 814.29 | 701.00 | 1680.75 | 0.4171 | -0.1335 |
SK-BR-3 | Taxol | 0.001 | uM | 4 | 1250.00 | 814.29 | 1493.00 | 1680.75 | 0.8883 | 0.7858 |
SK-BR-3 | Omipalisib | 0.31623 | uM | 4 | 1250.00 | 814.29 | 588.00 | 1680.75 | 0.3498 | -0.2676 |
SK-BR-3 | Omipalisib | 0.031623 | uM | 4 | 1250.00 | 814.29 | 814.00 | 1680.75 | 0.4843 | -0.0003 |
SK-BR-3 | Methotrexate | 10 | uM | 4 | 1250.00 | 814.29 | 1339.00 | 1680.75 | 0.7967 | 0.6092 |
SK-BR-3 | Omipalisib | 0.01 | uM | 4 | 1250.00 | 814.29 | 754.00 | 1680.75 | 0.4486 | -0.0709 |
SK-BR-3 | Omipalisib | 3.1623 | uM | 4 | 1250.00 | 814.29 | 539.00 | 1680.75 | 0.3207 | -0.3261 |
SK-BR-3 | 0 | uM | 4 | 1250.00 | 814.29 | 1293.00 | 1680.75 | 0.7693 | 0.5563 | |
SK-BR-3 | 0 | uM | 4 | 1250.00 | 814.29 | 1649.00 | 1680.75 | 0.9811 | 0.9639 | |
SK-BR-3 | 0 | uM | 4 | 2500.00 | 1726.92 | 3088.00 | 3011.25 | 1.0255 | 1.0637 | |
SK-BR-3 | 0 | uM | 4 | 2500.00 | 1726.92 | 3464.00 | 3011.25 | 1.1504 | 1.3816 |